Along with overexpression, CDK4/6 upregulation is a common occurrence in various malignancies (melanoma, leukemia, lymphoma, glioma, sarcoma, etc.)with distinct tissue selectivity for CDK4/6. Here, CDK4 is linked to melanoma.